FrancophonIA/ELRC3.0 huggingface dataset:
English: Other antihypertensive agents may increase the hypotensive effects of irbesartan; however Ifirmasta has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Maltese: Mediċini oħra kontra l-pressjoni għolja jistgħu jżidu l-effetti ta' tnaqqis fil-pressjoni ta' irbesartan; madankollu Ifirmasta ingħata mingħajr periklu ma' mediċini oħra ta' kontra l-pressjoni għolja, bħal beta-blockers, imblokkaturi tal-kanali ta' calcium li jaħdmu fit-tul, u dijuretiċi thiazides.
English: Subgroups consisting of gender, race, age, duration of diabetes, baseline blood pressure, serum creatinine, and albumin excretion rate were assessed for treatment effect.
Maltese: Sotto gruppi ta' sess, razza, età, tul tad-dijabete, il-linja bażi tal-pressjoni, kreatinina fis-serum, u rata ta' tneħħija t'albumina ġew assessjati għall-effett tal-kura.
English: Less than 2% of the dose is excreted in the urine as unchanged irbesartan.
Maltese: Inqas minn 2% tad-doża tiġi eliminata fl-awrina bħala irbesartan mhux mibdul.
English: Respiratory, thoracic and mediastinal disorders: Uncommon: cough
Maltese: Disturbi respiratorji, toraċiċi u medjastinali:
English: Potassium supplements and potassium-sparing diuretics:
Maltese: Supplimenti tal-potassium u dijuretiċi li ma jnixxux il-potassju:
English: Ifirmasta 75 mg film-coated tablets Each film-coated tablet contains 75 mg irbesartan (as hydrochloride).
Maltese: Ifirmasta 75 mg pilloli miksija b'rita Kull pillola miksija b'rita fiha 75 mg irbesartan (bħala hydrochloride).
English: - Uncommon (may affect up to 1 in 100 people): heart rate increased, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance), chest pain.
Maltese: - Mhux komuni (jistgħu jaffettwaw sa persuna waħda minn kull 100): taħbit tal-qalb aktar mgħaġġel, fwawar, sogħla, dijarea, indiġestjoni/qrusa fl-istonku, problemi ta' funzjoni sesswali (problemi fl-attività sesswali), uġigħ fis-sider.
English: - Common (may affect up to 1 in 10 people): dizziness, feeling sick/vomiting, and fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme).
Maltese: - Komuni (jistgħu jaffettwaw sa persuna waħda minn kull 10): sturdament, dardir/rimettar u għeja u testijiet tad-demm jistgħu juru livelli ogħla ta' enzim li jkejjel il-funzjoni tal-muskolu u talqalb (enzim ta' creatine kinase).
English: Ifirmasta 150 mg film-coated tablets are available in boxes of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters and in boxes of 56 x 1 film-coated tablets in perforated unit dose blisters.
Maltese: Ifirmasta 150 mg pilloli miksija b'rita huma disponibbli f'kaxxi ta' 14, 28, 30, 56, 84, 90 u 98 pillola miksija b'rita ġo folji u f'ta'56 x 1 pillola miksija b'rita ta' doża waħda ġo folja pperforata.
English: There was no evidence of abnormal systemic or target organ toxicity at clinically relevant doses.
Maltese: Ma kienx hemm evidenza ta' tossiċità sistemika anormali jew tossiċità fl-organu bersalljat b'dożi klinikament rilevanti.
English: Ifirmasta 75 mg film-coated tablets Irbesartan
Maltese: Ifirmasta 75 mg pilloli miksija b'rita Irbesartan
English: In the female and black subgroups which represented 32% and 26% of the overall study population respectively, a renal benefit was not evident, although the confidence intervals do not exclude it. As for the secondary endpoint of fatal and non-fatal cardiovascular events, there was no difference among the three groups in the overall population, although an increased incidence of non-fatal MI was seen for women and a decreased incidence of non-fatal MI was seen in males in the irbesartan group versus the placebobased regimen.
Maltese: Għall-endpoint sekondarju ta' każijiet kardjovaskulari fatali u mhux fatali, ma kienx hemm differenza bejn it-tliet gruppi tal-pazjenti fil-popolazzjoni totali, għalkemm inċidenza akbar ta' MI mhux fatali ġiet murija f'nisa u inċidenza inqas ta' MI mhux fatali ġiet murija f'irġiel fil-grupp t'irbesartan kontra l-grupp ibbażat fuq il-plaċebo.
English: Irbesartan
Maltese: Bijotrasformazzjoni
English: Ifirmasta 300 mg film-coated tablets are available in boxes of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters and in boxes of 56 x 1 film-coated tablets in perforated unit dose blisters.
Maltese: Ifirmasta 300 mg pilloli miksija b'rita huma disponibbli f'kaxex ta' 14, 28, 30, 56, 84, 90 u 98 pillola miksija b'rita f'folji u f'kaxxi b'56 x 1 pillola miksija b'rita ta' doża waħda ġo folja pperforata.
English: In diabetic hypertensive patients with microalbuminuria and normal renal function, orthostatic dizziness and orthostatic hypotension were reported in 0.5% of the patients (i.e., uncommon) but in excess of placebo.
Maltese: F'pazjenti dijabetiċi bi pressjoni għolja b'mikroalbuminurja u funzjoni normali tal-kliewi, sturdament ortostatiku u pressjoni baxxa ortostatika ġew irrapportati f'0.5% tal-pazjenti (jiġifieri mhux komuni) iżda iżjed milli fil-grupp tal-plaċebo.
English: In patients not adequately controlled by irbesartan alone, the addition of a low dose of hydrochlorothiazide (12.5 mg) to irbesartan once daily results in a further placebo-adjusted blood pressure reduction at trough of 7-10/3-6 mm Hg (systolic/diastolic).
Maltese: F'pazjenti li mhux ikkontrollati sew b'irbesartan waħdu, iż-żieda ta' doża baxxa ta' hydrochlorothiazide (12.5 mg) ma' irbesartan darba kuljum tirriżulta fi tnaqqis aktar tal-pressjoni fl-inqas livell ta' 7-10/3-6 mm/Hg (sistolika/dijastolika) meta aġġustata għall-plaċebo.
English: Hepatobiliary disorders: Uncommon: jaundice Not known:
Maltese: Disturbi tas-sistema immuni: Mhux magħrufa:
English: Ifirmasta 150 mg film-coated tablets Each film-coated tablet contains 150 mg irbesartan (as hydrochloride).
Maltese: Ifirmasta 150 mg pilloli miksija b'rita Kull pillola miksija b'rita fiha 150 mg irbesartan (bħala hydrochloride).
English: The decrease in blood pressure is dose-related for once a day doses with a tendency towards plateau at doses above 300 mg. Doses of 150-300 mg once daily lower supine or seated blood pressures at trough (i.e. 24 hours after dosing) by an average of 8-13/5-8 mm Hg (systolic/diastolic) greater than those associated with placebo.
Maltese: Dożi ta' 150-300 mg darba kuljum iniżżlu l-pressjoni meħudha meta pazjent ikun mindud jew bil-qiegħda (i.e. 24 siegħa wara id-doża) b'medja ta' 8-13/5-8 mm Hg (sistolika/dijastolika) aktar milli minn dawk bil-plaċebo.
English: Once daily dosing with 150 mg produced trough and mean 24 hour responses similar to twice daily dosing on the same total dose.
Maltese: Doża darba kuljum ta' 150 mg tat respons baxx u medju fuq 24 siegħa simili għal doża doppja ta' kuljum fuq l-istess doża totali.
English: Ifirmasta belongs to a group of medicines known as angiotensin-II receptor antagonists.
Maltese: Ifirmasta jappartjeni għall-grupp ta' mediċini magħrufa bħala antagonisti tar-riċetturi angiotensin-II.
English: The pharmacokinetics of irbesartan were evaluated in 23 hypertensive children after the administration of single and multiple daily doses of irbesartan (2 mg/kg) up to a maximum daily dose of 150 mg for four weeks.
Maltese: Il-farmakokinetiċi ta' irbesartan kienu evalwati fi 23 tifel u tifla bi pressjoni għolja wara l-għoti ta' doża waħda jew aktar kuljum ta' irbesartan (2 mg/kg) sa doża massima ta' kuljum ta' 150 mg għal erba' ġimgħat.
English: Diabetes Mellitus (IRMA 2)” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria.
Maltese: L-istudju ta' “L-effetti ta'Irbesartan fuq il-Mikroalbuminurja f'Pazjenti bi Pressjoni Għolja b'Dijabete Mellitus ta' Tip 2 (IRMA)”, juri li irbesartan 300 mg jittardja il-progressjoni għal protejnurja li tidher f'pazjenti b'mikroalbuminurja.
English: Ifirmasta 300 mg film-coated tablets Irbesartan
Maltese: Ifirmasta 300 mg pilloli miksija b'rita Irbesartan
English: The study examined the long-term effects (2 years) of irbesartan on the progression to clinical (overt) proteinuria (urinary albumin excretion rate (UAER) > 300 mg/day, and an increase in UAER of at least 30% from baseline).
Maltese: L-istudju eżamina l-effetti fit-tul (sentejn) ta' Ifirmasta fuq il-progressjoni għal protejnurja klinikali (li tidher) (ir-rata ta' tneħħija t'albumina fl-urina (UAER)
English: Ifirmasta 150 mg film-coated tablets Irbesartan
Maltese: Ifirmasta 150 mg pilloli miksija b'rita irbesartan
English: Ifirmasta at a dose of 150 mg once daily generally provides a better 24 hour blood pressure control than 75 mg.
Maltese: Ifirmasta b'doża ta' 150 mg darba kuljum ġeneralment jipprovdi kontroll aħjar matul l-24 siegħa għall-pressjoni tad-demm minn 75 mg.
English: As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function.
Maltese: Bħalma jseħħ bl-inibituri ACE, l-użu konkomitanti ta' antagonisti ta' angiotensin II u NSAIDs jista' jirriżulta f'żjieda fir-riskju li teħżien ilfunzjoni renali, inkluża l-possibbilità ta' insuffiċjenza renali akuta, u żjieda fil-potassium fis-serum, speċjalment f'pazjenti li diġà kellhom funzjoni renali batuta.
English: Irbesartan and its metabolites are eliminated by both biliary and renal pathways.
Maltese: Irbesartan u l-metaboliti tiegħu jiġu eliminati permezz ta' sistemi biljari u renali.
English: Rreversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Maltese: Żjidiet riversibbli tal-konċentrazzjonijiet u tossiċità ta' lithium fis-serum ġew irrapportati waqt lamministrazzjoni konkomitanti ta' lithium ma' inibituri ta' enzimi li jikkonvertu angiotensin.
English: C irbesartan, 80-85% of the circulating plasma radioactivity is attributable to unchanged irbesartan.
Maltese: C irbesartan mill-ħalq jew ġol-vini, 80-85% tar-radjuattività li tiċċirkola fil-plażma hi attribwita għal irbesartan mhux mibdul.
English: Each film-coated tablet contains 75 mg irbesartan (as hydrochloride).
Maltese: Kull pillola miksija b'rita fiha 75 mg ta' irbesartan (bħala hydrochloride).
English: Uncommon: may affect up to 1 in 100 people
Maltese: Mhux komuni: jistgħu jaffettwaw sa persuna waħda minn kull'100
English: 56 tablets: EU/1/08/480/009
Maltese: EU/1/08/480/009
English: There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system.
Maltese: Hemm riskju ikbar ta' pressjoni baxxa severa u ta' insuffiċjenza renali meta pazjenti li għandhom stenosi bilaterali ta' l-arterja renali jew stenosi ta' l-arterja b'kilwa waħda taħdem, jiġu kkurati bi prodotti mediċinali li jaffettwaw is-sistema renin-angiotensin-aldosterone.
English: 56 x 1 tablets: EU/1/08/480/016 84 tablets: EU/1/08/480/017
Maltese: EU/1/08/480/016 84 pillola:
English: Ifirmasta 300 mg film-coated tablets Each film-coated tablet contains 300 mg irbesartan (as hydrochloride).
Maltese: Kull pillola miksija b'rita fiha 300 mg ta' irbesartan (bħala hydrochloride).
English: The “Irbesartan Diabetic Nephropathy Trial (IDNT)” shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria.
Maltese: Il-“Prova Dijabete Nefropatika b'Irbesartan (IDNT)” juri li irbesartan inaqqas il-progressjoni tal-mard renali fil-pazjenti b'insuffiċjenza renali kronika u bi protejnurja li tidher.
English: 30 tablets: EU/1/08/480/021
Maltese: EU/1/08/480/021
English: 30 tablets: EU/1/08/480/023
Maltese: EU/1/08/480/023
English: 56 x 1 tablets: EU/1/08/480/010 84 tablets: EU/1/08/480/011
Maltese: EU/1/08/480/010 84 pillola:
English: 56 tablets: EU/1/08/480/015
Maltese: EU/1/08/480/015
English: hyperkalaemia
Maltese: Indeboliment epatiku
English: You may need to have blood checks if you take: - potassium supplements, - salt substitutes containing potassium, - potassium-sparing medicines (such as certain diuretics), - medicines containing lithium.
Maltese: Jista' jkollok bżonn tagħmel kontrolli tad-demm jekk int qed tieħu: - supplimenti tal-potassium, - sostituti tal-melħ li fihom il-potassium, - mediċini potassium-sparing (bħal ċerti dijuretiċi) - mediċini li fihom il-lithium.
English: Film coating:
Maltese: Mhux komuni:
English: 28 tablets: EU/1/08/480/008
Maltese: EU/1/08/480/008
English: Renal impairment and kidney transplantation
Maltese: Indeboliment renali u trapjant tal-kliewi
English: 90 tablets: EU/1/08/480/022
Maltese: EU/1/08/480/022
English: Safety features will be implemented until 9/2/2019.
Maltese: Il-karatteristiċi tas-sikurezza għandhom jiġu implimentati sa 9/2/2019
English: Hyperkalemia
Maltese: iperkalemija
English: Each film-coated tablet contains 300 mg irbesartan (as hydrochloride).
Maltese: Kull pillola miksija b'rita fiha:300 mg irbesartan (bħala hydrochloride).
English: 28 tablets: EU/1/08/480/014
Maltese: EU/1/08/480/014
English: Each film-coated tablet contains 150 mg irbesartan (as hydrochloride).
Maltese: Kull pillola miksija b'rita fiha 150 mg ta' irbesartan (bħala hydrochloride).
English: 90 tablets: EU/1/08/480/024
Maltese: EU/1/08/480/024
English: Over a subsequent two week period where patients were re-randomized to either active medicinal product or placebo, patients on placebo had increases of 2.4 and 2.0 mmHg in SeSBP and SeDBP compared to +0.1 and -0.3 mmHg changes respectively in those on all doses of irbesartan (see section 4.2).
Maltese: Fuq il-perjodu tal-ġimagħtejn ta' wara fejn il-pazjenti ġew magħżulin b'mod każwali mill-ġdid jew għal prodott mediċinali attiv jew għal plaċebo il-pazjenti fuq plaċebo kellhom żidiet ta' 2.4 u 2.0 mmHg fis-SeSBP u SeDBP meta mqabbla ma' bidliet rispettivi ta' +0.1 u 0.3 mmHg f'dawk fuq id-dożi kollha ta' irbesartan (ara sezzjoni 4.2).
English: How to take Ifirmasta
Maltese: Twissijiet u prekawzjonijiet
English: 98 tablets: EU/1/08/480/012
Maltese: EU/1/08/480/012
English: The most likely manifestations of overdosage are expected to be hypotension and tachycardia; bradycardia might also occur from overdose.
Maltese: L-iktar manifestazzjonijiet probabbli ta' doża eċċessiva huma mistennija li jkunu pressjoni baxxa, u takikardija; bradikardija tista' wkoll tiġi ikkaġunata minn doża eċċessiva.
English: The usual dose is 150 mg once a day.
Maltese: Id-doża normali hija 150 mg darba kuljum.
English: Uncommon: diarrhoea, dyspepsia/heartburn Not known:
Maltese: Disturbi fil-qalb: Mhux komuni:
English: CARTON FOLDING BOX
Maltese: KAXXA TAL-KARTUN LI TINTEWA
English: Ifirmasta 75 mg film-coated tablets are available in boxes of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters and in boxes of 56 x 1 film-coated tablets in perforated unit dose blisters.
Maltese: Ifirmasta 75 mg pilloli miksija b'rita huma: pilloli miksija b'rita ta' lewn abjad u f'għamla ovaliIfirmasta 75 mg pilloli miksija b'rita huma disponibbli f'kaxex ta' 14, 28, 30, 56, 84, 90 u 98 pillola miksija b'rita f'folji u f'kaxxi ta'56 x 1 pillola miksija b'rita ta' doża waħda ġo folja pperforata.
English: IJ
Maltese: C
English: The demonstration of renal benefit of Ifirmasta in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see sections 4.3, 4.4, 4.5 and 5.1).
Maltese: Il-benefiċċju renali muri b'Ifirmasta f'pazjenti b'dijabete ta' tip 2 li għandhom pressjoni għolja huwa bbażat fuq studji fejn irbesartan intuża flimkien ma' mediċini oħra ta' kontra l-pressjoni għolja kif meħtieġ, biex jintlaħaq il-livell mixtieq ta' pressjoni (ara sezzjonijiet 4.3, 4.4, 4.5 u 5.1).
English: arthralgia, myalgia (in some cases associated with increased plasma creatine kinase levels), muscle cramps
Maltese: artralġja, mijalġja (f'xi każijiet assoċjata ma' żieda fil-livelli ta' creatine kinase fil-plażma), bugħawwieġ fil-muskoli
English: 98 tablets: EU/1/08/480/018
Maltese: EU/1/08/480/018
English: - if you are taking any of the following medicines used to treat high blood pressure: - an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems, - aliskiren.
Maltese: - jekk qed tieħu xi waħda minn dawn il-mediċini li ġejjin li jintużaw għal kura ta' pressjoni taddemm għolja: - inibitur ta' ACE (pereżempju enalapril, lisinopril, ramipril), b'mod partikulari jekk għandek problemi tal-kliewi relatati mad-dijabete. - aliskiren.
English: Renal and urinary disorders: Not known:
Maltese: Disturbi fil-kliewi u fis-sistema urinarja:
English: Diuretics and other antihypertensive agents:
Maltese: Dijuretiċi u mediċini oħra kontra l-pressjoni għolja:
English: Very common: Hyperkalaemia* occurred more often in diabetic patients treated with irbesartan than with placebo.
Maltese: Iperkalimja* ġrat iktar frekwenti f'pazjenti dijabetiċi ikkurati b'irbesartan milli bil- plaċebo.
English: Patients with primary aldosteronism generally will not respond to antihypertensive medicinal products acting through inhibition of the renin-angiotensin system.
Maltese: Pazjenti b'aldosteroniżmu primarju ġeneralment ma jirrispondux għal prodotti mediċinali ta' kontra lpressjoni għolja li jaħdmu billi jimpedixxu s-sistema renin-angiotensin.
English: Animal studies with irbesartan showed transient toxic effects (increased renal pelvic cavitation, hydroureter or subcutaneous oedema) in rat foetuses, which were resolved after birth.
Maltese: Meta Ifirmasta jintuża f'pazjenti b'indeboliment renali, hija irrikmandata osservanza perjodika tallivelli tal-potassju u tal-kreatinina fis-serum.
English: Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP.
Maltese: Tużax din il-mediċina wara d-data ta' meta tiskadi li tidher fuq il-kartuna u fuq il-folja wara EXP.
English: Dual blockade of the renin-angiotensin-aldosterone system (RAAS) There is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure).
Maltese: Hemm evidenza li l-użu fl-istess ħin ta' inibituri ta' ACE, imblokkaturi tar-riċetturi ta' angiotensin II jew aliskiren iżid ir-riskju ta' pressjoni baxxa, iperkalimja u tnaqqis fil-funzjoni tal-kliewi (li jinkludi insuffiċjenza akuta tal-kliewi).
English: Reproductive system and breast disorders: Uncommon: sexual dysfunction
Maltese: Disturbi fis-sistema riproduttiva u fis-sider: Mhux komuni:
English: INN/Active substance + Strength
Maltese: INN/Sustanza Attiva + Saħħa
English: Oral Suspension
Maltese: Sospensjoni orali
English: Deutsche Bundeswehr Kommando Sanitätsdienst der Bundeswehr
Maltese: Il-Ġermanja Deutsche Bundeswehr Kommando Sanitätsdienst der Bundeswehr
English: Ro-Farm Di Salvatore De Maio & C. S.A.S.
Maltese: Ro-Farm Di Salvatore De Maio & C.
English: Tchaikapharma High Quality Medicines, Inc.
Maltese: Il-Bulgarija Tchaikapharma High Quality Medicines, Inc.
English: Iip - Institut Für Industrielle Pharmazie Forschungs- Und Entwicklungsgesellschaft Mbh
Maltese: Il-Ġermanja Iip - Institut Für Industrielle Pharmazie Forschungs- Und Entwicklungsgesellschaft Mbh
English: Special Medicines Pharmaceutical Products SingleMember Private Company (Pc)
Maltese: Special Medicines Pharmaceutical Products Single-Member Private Company (Pc)
English: Teva Denmark A/S
Maltese: Id-Danimarka Teva Denmark A/S
English: Tecnimede - Sociedade TécnicoMedicinal, Sa
Maltese: Tecnimede - Sociedade Técnico-Medicinal, Sa
English: Sanovel Holding B.V.
Maltese: Il-Ġermanja Sanovel Holding B.V.
English: Czech Republic Pro.Med.Cs Praha A.S.
Maltese: Is-Slovakkja Pro.Med.Cs Praha A.S.
English: Granules And Solvent For Oral Suspension
Maltese: Granuli u solvent għal sospensjoni orali
English: Antibiotic-Razgrad Ad левофлоксан
Maltese: Il-Bulgarija Antibiotic-Razgrad Ad левофлоксан
English: Actavis Ead нелидикс
Maltese: Il-Bulgarija Actavis Ead нелидикс
English: Dr. R. Pfleger Chemische Fabrik Gmbh
Maltese: Il-Ġermanja Dr. R. Pfleger Chemische Fabrik Gmbh
English: Docpharm Arzneimittelvertrieb GmbH & Co.
Maltese: Il-Ġermanja Docpharm Arzneimittelvertrieb GmbH & Co.
English: Czech Republic Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F.
Maltese: Is-Slovakkja Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F.
English: Netherlands Hexal Ag
Maltese: In-Netherlands Hexal Ag
English: Dr. Reddy's Laboratories Romania Srl
Maltese: Ir-Rumanija Dr. Reddy's Laboratories Romania Srl
English: Luxembourg Eurogenerics N.V./S.A.
Maltese: Eurogenerics N.V./S.
English: Chelonia Healthcare Limited Nalidixic Acid Chelonia Healthcare
Maltese: Ir-Renju Unit Chelonia Healthcare Limited Nalidixic Acid Chelonia Healthcare
English: Heumann Pharma Gmbh & Co. Generica Kg
Maltese: Il-Ġermanja Heumann Pharma Gmbh & Co. Generica Kg
English: Enoxacin Sesquihydrate 217mg Tablet
Maltese: Pillola ta' Enoxacin Sesquihydrate 217mg
English: Aurobindo Pharma (Malta) Limited ципрофлоксацин уробиндо
Maltese: Il-Bulgarija Aurobindo Pharma (Malta) Limited ципрофлоксацин уробиндо
English: FARMAPLANT Fabrikation chemischer Produkte GmbH
Maltese: Il-Ġermanja FARMAPLANT Fabrikation chemischer Produkte GmbH
English: Elpen Pharmaceutical Co. Inc.
Maltese: Elpen Pharmaceutical Co.
English: Nobel Pharma Co., Ltd.
Maltese: Il-Bulgarija Nobel Pharma Co., Ltd.
English: Pharmacodane Aps
Maltese: Id-Danimarka Pharmacodane Aps
English: Belgium Sanofi Belgium
Maltese: Sanofi Belgium
English: Belgium Bayer Sa Nv
Maltese: Bayer Sa Nv
English: Stada Arzneimittel Ag вивекс
Maltese: Il-Bulgarija Stada Arzneimittel Ag вивекс
English: Alkaloid Ltd ципрофлоксацин алкалоид
Maltese: Il-Bulgarija Alkaloid Ltd ципрофлоксацин алкалоид
English: Sopharma Ad ципрофлоксацин софарма
Maltese: Ad ципрофлоксацин софарма
English: Belgium Hospira Benelux Bvba
Maltese: Hospira Benelux Bvba
English: Adipharm Ead левофлоксацин адифарм
Maltese: Il-Bulgarija Adipharm Ead левофлоксацин адифарм
English: Sanofi-Aventis Bulgaria Eood таваник
Maltese: Il-Bulgarija Sanofi-Aventis Bulgaria Eood таваник
English: Aristo Pharma Gmbh (Art 57) Levofloxacin Aristo
Maltese: Il-Ġermanja Aristo Pharma Gmbh (Art 57) Levofloxacin Aristo
English: Ksk-Pharma Ag
Maltese: Il-Ġermanja Ksk-Pharma Ag
English: Flumequine 0.4g Tablet
Maltese: Pillola ta' Flumequine 0.4g Pillola
English: Ecopharm Group ципрофлоксацин екофарм
Maltese: Il-Bulgarija Ecopharm Group ципрофлоксацин екофарм
English: Teva Pharmaceuticals Cr, S.R.O.
Maltese: Is-Slovakkja Teva Pharmaceuticals Cr, S.R.O.
English: Betapharm Arzneimittel Gmbh Ciprobeta
Maltese: Il-Ġermanja Betapharm Arzneimittel Gmbh Ciprobeta
English: Bristol Laboratories Ltd (Berkhamsted)
Maltese: Ir-Renju Unit Bristol Laboratories Ltd (Berkhamsted)
English: Netherlands Hospira Benelux Bvba
Maltese: In-Netherlands Hospira Benelux Bvba
English: Ecopharm Group левофлоксацин екофарм
Maltese: Il-Bulgarija Ecopharm Group левофлоксацин екофарм
English: Luxembourg Sandoz N.V.
Maltese: Sandoz N.V.
English: Sanofi-Aventis Norge As
Maltese: In-Norveġja Sanofi-Aventis Norge As
English: Netherlands Pharmathen S.A.
Maltese: In-Netherlands Pharmathen S.A.
English: Netherlands Bayer Bv
Maltese: In-Netherlands Bayer Bv
English: Costakis Tsisios & Co. Ltd
Maltese: Costakis Tsisios & Co.
English: Axcount Generika Gmbh
Maltese: Il-Ġermanja Axcount Generika Gmbh
English: 250mg Tablet
Maltese: 250mg
English: Pierre Fabre Pharma Gmbh / Germany
Maltese: Il-Ġermanja Pierre Fabre Pharma Gmbh / Germany
English: Antibiotice Sa
Maltese: Ir-Rumanija Antibiotice Sa
English: Intravenous Use
Maltese: Infużjoni intravenuża
English: Beximco Pharma Uk Ltd левофлоксацин бексимко
Maltese: Il-Bulgarija Beximco Pharma Uk Ltd левофлоксацин бексимко
English: Benedetti & Co. S.P.A.
Maltese: Benedetti & Co.
English: Belgium Fresenius Kabi Nv/Sa
Maltese: Fresenius Kabi Nv/Sa
English: Stada Arzneimittel Ag моксистад
Maltese: Il-Bulgarija Stada Arzneimittel Ag моксистад